<DOC>
	<DOCNO>NCT00348881</DOCNO>
	<brief_summary>This study compare safety immune response pentavalent DTaP-HB-PRP~T combine vaccine Tritanrix-HepB/Hib™ , give concomitantly OPV 6 , 10 , 14 week age .</brief_summary>
	<brief_title>Study Comparing DTaP-HB-PRP~T Combined Vaccine With Tritanrix HepB/Hib™ , Concomitantly With OPV Healthy Infants</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Whooping Cough</mesh_term>
	<mesh_term>Tetanus</mesh_term>
	<mesh_term>Diphtheria</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>At Screening : 0 3 day old infant Born full term pregnancy ( ≥ 37 week ) birth weight ≥ 2.5 kg Apgar score ≥ 7 three minute birth Informed consent form sign one parent legal representative appropriate ( independent witness mandatory parent illiterate ) At Inclusion : Six week age Received dose Hepatitis B ( HB ) first three day life Able attend schedule visit comply trial procedure . At Screening : Illness stage could interfere trial conduct completion Any vaccination HB vaccination ( except bacille CalmetteGuérin [ BCG ] give birth ) Vaccination plan 4 6 week follow first trial vaccination ( except BCG give birth ) Acute illness day screen . At Screening Inclusion : Blood bloodderived product receive since birth Planned participation another clinical trial present trial period Mother know seropositive Human immunodeficiency virus ( HIV ) Hepatitis C , carry HB surface antigen ( HBsAg ) Known thrombocytopenia bleed disorder contraindicate intramuscular vaccination Known hypersensitivity component vaccine use trial ( include neomycin polymixin B ) At Inclusion : Nontrial vaccine administer since birth , except Bacille CalmetteGuérin ( BCG ) Participation another clinical trial first trial vaccination Congenital acquire immunodeficiency , immunosuppressive therapy longterm systemic corticosteroid therapy Systemic hypersensitivity vaccine component history life threaten reaction trial vaccine vaccine contain substance Chronic illness stage could interfere trial conduct completion Vaccination study vaccine plan 12 week follow inclusion Documented history pertussis , tetanus , diphtheria , polio , H. influenza type b , HB infection ( confirm clinically , serologically , microbiologically ) History seizure Febrile ( rectal temperature ≥ 38.0°C ) acute illness day inclusion .</criteria>
	<gender>All</gender>
	<minimum_age>42 Days</minimum_age>
	<maximum_age>50 Days</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Diphtheria</keyword>
	<keyword>Tetanus</keyword>
	<keyword>Pertussis</keyword>
	<keyword>Hepatitis B Hansenula ( HB )</keyword>
	<keyword>Haemophilus influenzae type b</keyword>
</DOC>